European Pharmaceutical Review Launches Their New Media Planner for 2016

The publication European Pharmaceutical Review today announces the official launch of their new media planner for 2016.

Brasted, United Kingdom (November 17, 2015) — The publication European Pharmaceutical Review today announces the official launch of their new media planner for 2016.

“Throughout 2015, we have seen a very successful year unfold, with visitor numbers soaring by more than 230% and website registrations up by more than 78%. These figures show that our audience is becoming more relevant and larger in size to fit our clients’ needs” Graeme Cathie, Publisher, European Pharmaceutical Review.

Responses from their 2015 industry survey confirmed that:
• 95% of their community work in pharma, biotech or academia
• More than 91% of their visitors have influential purchasing power
• They have an online satisfaction rating of over 93%
• Over 78% of their print readers are involved in the decision making process

Each of their print issues goes to the top 25 pharmaceutical and top 25 biotechnology companies as well as the leading 25 life science academic institutions. Now that advertising opportunities are nearly sold out for 2015 both digitally and in print, European Pharmaceutical Review is now selling advertising and sponsorship across its portfolio for 2016.

About European Pharmaceutical Review
European Pharmaceutical Review is the leading publication and website for information on technologies in drug discovery and manufacturing. Published bi-monthly, every issue offers a high level of technical and business contributions from the world’s leading pharmaceutical companies and academic institutions, coupled with a variety of exciting new features including interviews, updates and profiles.

http://www.europeanpharmaceuticalreview.com

For further information, please contact:
Graeme Cathie, Publisher
European Pharmaceutical Review
T: +44 (0)1959 563311
E: gcathie@russellpublishing.com
W: http://www.europeanpharmaceuticalreview.com

Leave a Reply